Together, this suggests that fAD‐associated mutations to PSEN1 in astrocytes affect APP processing and therefore will enable us to determine the impact of altered amyloid production of metabolic and disease associated phenotypes. This evidence concerns the gene APP and familial Alzheimer disease.